acut
respiratori
infect
ari
respons
substanti
morbid
mortal
global
especi
children
year
age
highest
burden
observ
develop
nation
approxim
million
ariassoci
death
occur
among
children
year
age
africa
southeast
asia
bacteria
virus
identifi
etiolog
agent
ari
virus
frequent
detect
children
ari
includ
respiratori
syncyti
viru
rsv
influenza
viru
inf
type
b
adenoviru
av
parainfluenza
viru
piv
human
metapneumoviru
hmpv
rhinoviru
rv
howev
clinic
present
respiratori
tract
infect
similar
make
difficult
distinguish
etiolog
agent
without
laboratori
diagnosi
addit
interpret
viral
detect
complic
fact
infect
multipl
virus
common
children
ari
mani
virus
frequent
found
asymptomat
children
streptococcu
pneumonia
haemophilu
influenza
type
b
hib
commonli
isol
bacteria
ari
case
atyp
pathogen
mycoplasma
pneumonia
chlamydophila
pneumonia
less
frequent
report
pneumonia
hib
commonli
identifi
nasopharyng
sampl
asymptomat
children
due
high
rate
carriag
howev
identif
nasopharynx
rare
indic
invas
diseas
viral
bacteri
etiolog
ari
well
document
countri
northern
hemispher
howev
studi
avail
africa
niger
sentinel
surveil
system
influenza
virus
institut
april
howev
studi
etiolog
ari
conduct
countri
aim
document
preval
select
viral
bacteri
infect
among
children
year
age
hospit
sever
acut
respiratori
ill
sari
select
hospit
niger
januari
decemb
niger
west
african
countri
saharan
climat
character
four
distinct
season
cold
season
middecemb
midfebruari
dri
hot
season
midfebruari
may
raini
season
june
septemb
hot
season
octob
middecemb
sinc
april
influenza
surveil
conduct
among
patient
hospit
sever
acut
respiratori
ill
sari
sentinel
site
locat
region
countri
centr
de
recherch
et
sanitair
cerm
nation
refer
laboratori
influenza
influenza
surveil
program
niger
previous
describ
briefli
patient
hospit
particip
sentinel
site
met
sari
case
definit
elig
enrol
verbal
inform
consent
obtain
case
year
age
older
proxi
inform
consent
obtain
parent
legal
guardian
minor
patient
meet
case
definit
provid
verbal
consent
includ
sari
case
defin
hospit
child
year
age
onset
cough
difficulti
breath
within
day
prior
admiss
least
one
follow
danger
sign
inabl
drink
breastfe
lethargi
vomit
everyth
convuls
nasal
flare
chest
indraw
stridor
calm
child
tachypnea
standard
questionnair
administr
clinic
personnel
record
patient
demograph
characterist
medic
histori
question
includ
inform
date
enrol
symptom
onset
sex
age
clinic
symptom
nasopharyng
np
swab
collect
enrol
case
place
cryovial
contain
viru
transport
medium
copan
kit
itali
specimen
kept
refriger
sentinel
site
transport
twice
weekli
cerm
test
sampl
aliquot
screen
influenza
b
virus
realtim
revers
transcript
polymeras
chain
reaction
rrtpcr
store
conduct
retrospect
studi
etiolog
influenzaneg
sari
case
among
children
year
age
enrol
influenza
surveil
januari
decemb
niger
randomli
select
use
random
select
procedur
avail
stata
sampl
store
np
specimen
sari
case
test
influenza
b
neg
sampl
repres
total
case
age
year
enrol
studi
period
sari
case
year
old
age
group
test
posit
influenza
influenzaposit
case
mainli
detect
cold
season
nucleic
acid
extract
use
qiaamp
mini
kit
qiagen
germani
accord
manufactur
protocol
intern
control
ic
ad
extract
tube
order
assess
qualiti
extract
end
amplif
extract
sampl
screen
rrtpcr
fast
track
diagnost
ftd
respiratori
pathogen
kit
luxemburg
follow
manufactur
procedur
use
six
multiplex
pcr
virus
influenza
inf
type
b
parainfluenza
viru
piv
type
coronaviru
cv
metapneumoviru
ab
hmpv
respiratori
syncyti
viru
ab
rsv
parechoviru
pv
enteroviru
ev
adenoviru
av
human
bocaviru
hbv
rhinoviru
rv
bacteri
pathogen
mycoplasma
pneumonia
pneumonia
chlamydophila
pneumonia
c
pneumonia
streptococcu
pneumonia
pneumonia
haemophilu
influenza
type
b
hib
staphylococcu
aureu
aureu
two
differ
posit
control
viral
bacteri
multiplex
pcr
reaction
neg
control
tube
provid
kit
fisher
exact
test
use
assess
differ
categor
variabl
compar
expect
observ
frequenc
across
evalu
group
addit
compar
characterist
select
nonselect
children
includ
influenzaposit
case
use
statist
statist
analysi
implement
use
stata
version
texa
usa
nation
ethic
committe
niger
approv
nation
influenza
surveil
program
refer
april
prior
investig
respiratori
pathogen
ministri
health
provid
extend
approv
access
studi
sampl
grant
director
cerm
januari
decemb
enrol
children
year
age
hospit
sari
influenza
surveil
program
test
neg
influenza
viru
randomli
select
studi
age
sex
symptom
durat
distribut
differ
significantli
among
select
nonselect
children
includ
test
posit
influenza
howev
among
select
group
significantli
lower
proport
specimen
collect
cold
season
major
influenzaposit
case
detect
exclud
random
tabl
among
select
children
year
age
median
age
among
children
age
year
month
femal
durat
symptom
day
patient
present
record
temperatur
cough
dyspnea
chest
indraw
patient
present
tachypnea
difficulti
breastfeed
overal
children
includ
studi
test
posit
least
one
pathogen
viral
bacteri
least
one
respiratori
viru
detect
sampl
least
one
bacterium
detect
sampl
among
sampl
posit
pathogen
posit
singl
pathogen
posit
pneumonia
rsv
rv
hmpv
cv
piv
hib
account
individu
singl
organ
detect
fig
among
children
organ
detect
viral
bacteri
pathogen
detect
sampl
among
sampl
test
rsv
n
frequent
detect
viru
follow
rv
n
piv
type
n
tabl
cv
hmpv
hbv
ev
av
detect
individu
specimen
pv
detect
studi
sampl
test
posit
cv
type
type
type
type
sampl
test
posit
piv
type
type
type
type
even
though
select
influenza
b
neg
sampl
detect
infa
infb
posit
sampl
fast
track
platform
codetect
differ
subtyp
detect
cv
piv
posit
case
respect
rsv
piv
hmpv
detect
frequent
infant
year
age
compar
children
year
age
tabl
rsv
piv
hmpv
detect
frequent
hot
season
octob
middecemb
rv
hbv
detect
frequent
raini
season
june
septemb
virus
detect
similar
frequenc
across
season
tabl
among
sampl
test
pneumonia
n
frequent
detect
bacteria
follow
hib
n
aureu
n
c
pneumonia
n
tabl
pneumonia
detect
studi
report
detect
rate
select
viral
bacteri
pathogen
among
children
year
age
hospit
sari
niger
detect
respiratori
virus
studi
sampl
high
detect
rate
virus
found
studi
consist
result
similar
studi
conduct
burkina
faso
kenya
brazil
howev
lower
rate
viral
detect
report
studi
countri
ghana
china
egypt
differ
attribut
differ
climat
condit
enrol
criteria
case
definit
test
platform
studi
rsv
predomin
viru
detect
commonli
found
children
year
age
rsv
report
import
pathogen
children
especi
young
infant
sever
studi
addit
rsv
detect
report
strongli
associ
ill
studi
compar
symptomat
case
control
rhinoviru
second
commonli
detect
viru
similar
rate
among
infant
year
age
children
age
year
report
previou
studi
howev
studi
report
rv
preval
viru
among
children
year
age
addit
rv
commonli
detect
among
asymptomat
person
sever
studi
indic
rv
act
pathogen
bystand
consequ
hinder
abil
infer
associ
detect
ill
among
piv
cv
detect
studi
piv
type
cv
type
common
viru
type
report
studi
also
found
high
detect
rate
bacteri
pathogen
pneumonia
hib
common
bacteria
detect
nasopharyng
specimen
elev
colon
rate
bacteria
report
children
proport
colon
result
invas
diseas
high
detect
rate
pneumonia
studi
like
due
fact
pneumonia
commens
nasopharynx
shown
preval
pneumonia
carriag
healthi
children
year
age
rang
low
incom
countri
detect
pneumonia
steril
site
like
blood
cerebrospin
fluid
reflect
invas
pneumococc
diseas
shown
lower
nonetheless
pneumonia
report
respons
mening
case
niger
base
cerebrospin
fluid
test
differ
serotyp
detect
among
case
mening
prior
introduct
pneumococc
conjug
vaccin
hib
aureu
preval
bacteri
pathogen
studi
also
shown
commens
organ
high
nasopharyng
carriag
rate
especi
young
children
substanti
hib
nasopharyng
colon
densiti
found
studi
investig
hib
vaccin
avail
niger
expand
immun
program
sinc
nasopharyng
specimen
may
use
aid
diagnosi
certain
bacteri
respiratori
pathogen
tend
colon
nasopharynx
pneumonia
c
pneumonia
c
pneumonia
detect
low
rate
pneumonia
detect
studi
use
serolog
method
preval
rate
high
report
c
pneumonia
contrast
studi
report
signific
detect
pneumonia
low
detect
c
pneumonia
studi
found
elev
preval
codetect
report
studi
shown
viral
infect
may
predispos
bacteri
superinfect
favor
bacteri
attach
site
nasopharyng
epitheli
cell
increas
mucou
product
promot
bacteri
growth
studi
limit
warrant
discuss
first
small
sampl
size
studi
hinder
abil
accur
assess
season
pathogen
includ
studi
nonetheless
result
suggest
rsv
piv
hmpv
commonli
detect
hot
season
octob
decemb
rv
hbv
detect
frequent
raini
season
june
septemb
differ
detect
rate
virus
bacteria
note
across
season
studi
small
sampl
size
studi
also
hinder
abil
detect
pattern
codetect
associ
specif
viral
bacteri
codetect
second
keep
formal
record
proport
patient
consent
particip
sari
surveil
howev
review
perform
surveil
system
implement
hospit
record
review
sentinel
site
reveal
patient
met
studi
case
definit
miss
surveil
program
third
lack
control
studi
limit
abil
assess
associ
pathogen
detect
diseas
viral
bacteri
pathogen
identifi
studi
describ
previou
studi
caus
agent
ari
assign
causal
remain
challeng
fourth
influenzaposit
sampl
exclud
studi
codetect
viral
bacteri
pathogen
influenza
expect
may
result
underestim
preval
pathogen
includ
studi
especi
cold
season
major
influenzaposit
case
detect
last
systemat
collect
inform
progress
ill
includ
inhospit
outcom
risk
factor
sever
diseas
hinder
abil
evalu
pathogen
contribut
sever
spectrum
ill
identifi
group
high
risk
sever
diseas
studi
report
detect
rate
viral
bacteri
pathogen
among
children
year
age
hospit
sari
niger
high
preval
certain
viral
bacteri
pathogen
highlight
need
expand
surveil
niger
inform
polici
intervent
given
high
rsv
detect
rate
observ
studi
report
associ
rsv
detect
ill
rsv
includ
routin
surveil
program
niger
select
pathogen
could
consid
routin
surveil
countri
follow
assess
determin
associ
ill
addit
inform
progress
ill
includ
inhospit
outcom
risk
factor
sever
diseas
collect
routin
exist
surveil
system
